Skip to content
drillr
.ai
Product
▼
Datasets
▼
Docs
(opens in a new tab)
Pricing
Research
Benchmark
Sign in
Sign up
P
PTHS
Pelthos Therapeutics Inc.
US
US
—
+ Watch
Ask drillr
Overview
Financials
Valuation
Profitability
Growth
Capital
Momentum
Earnings
Ownership
News
Analysis
Jun 30, 2026, 00:00 UTC
Matthew Pauls was appointed as a Class I director of Palvella Therapeutics, Inc.